What it sells
RWE Generation in minutes
Business model breakdown
Buyer: who owns the budget?
UnverifiedReal-world evidence / HEOR / epidemiology leaders at pharma and biotech (inferred).
Trigger: what makes them buy now?
Traditional RWE studies cost $100K-$1M and take 6-18 months, with about 80% of the time spent on data prep.
Workflow: what inputs become what output?
Connect your own data (BYOD, mapped to OMOP), AI agents design the study, SAP and analysis, producing publication-ready results with auditable code.
Economics: what it saves and how it charges
Platform replacing 6-9 month manual workflows with hours/days; pricing model not stated.
Distribution: how it reaches customers
Demo-led ("Request a Demo"), segmented pages for pharma, biotech, CRO and researchers.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Spring 2025 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.